跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Irbedenz - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Irbedenz
Approved
STANDARD
Irbedenz
Sun Pharmaceutical Industries Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
00046ea2861d03c6
Company
Sun Pharmaceutical Industries Limited
Type
Standard
Approval Details
Approval Id
00046ea2861d03c6
Drug Approval Philippines Name
Irbedenz
Product Name
Irbedenz
Registration Number
DRP-2658-01
Brand Name
Irbedenz
Generic Name
Irbesartan
Dosage Form
Tablet
Dosage Strength
150 mg
Manufacturer
Sun Pharmaceutical Industries Limited
Importer
I.E. Medica, Inc.
Distributor
Vivilon Pharmaceuticals Inc.
Company Detail Path
/organization/sun-pharmaceutical-industries-limited
Issuance Date
27 October 2023
Expiry Date
23 December 2028
Pharmacologic Category
Angiotensin II Receptor Blocker
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
00046ea2861d03c6
Type
Standard
Back to Philippines FDA Approvals